Life Sciences
What’s on FDA’s new Diagnostics Chief’s mind? Transitions, the LDT rule and cybersecurity
Aug 20, 2024
Read More >>
Boost Your Regulatory IQ
Simplify the complex with customized blog posts on life sciences and chemical regulation from AgencyIQ. We bring daily updates and analysis on the things that matter to you—helping you get smarter about regulation on the horizon and your next course of action.
Life Sciences
EMA issues more updates to prepare for clinical trials transition
Aug 19, 2024
Read More >>
Life Sciences
Here’s how global regulators are starting to think about the use of AI in drug development
Aug 16, 2024
Read More >>Life Sciences
The FDA rejected a psychedelic sponsor’s bid for approval. Here are six industry takeaways
Aug 13, 2024
Read More >>
Life Sciences
Understanding the nuts and bolts of the reauthorization process for PDUFA VIII
Aug 09, 2024
Read More >>Chemicals
Commission proposes exemptions to UV-328 ban under POPs Regulation
Aug 06, 2024
Read More >>Life Sciences
FDA’s new metabolic diseases committee gives hesitant nod to ultra-rare disease drug
Aug 06, 2024
Read More >>Get an insider’s view on regulatory movements.
Sign up for AgencyIQ’s newsletters to receive exclusive regulatory updates and analysis impacting the life sciences, food, and chemical industry.